A Study to Evaluate the One-way Interaction of Calcium Carbonate, Omeprazole, or Rifampin on ACP-196

• Status: Completed
• Trial end date: 2014-10-16

Summary

The study will evaluate one-way interaction of calcium carbonate, omeprazole, or rifampin on ACP-196.

• Phase: Phase 1

Details

• Lead Sponsor: Acerta Pharma BV
• Treatments: Acalabrutinib; Calcium; Calcium Carbonate; Omeprazole; Rifampin